Jessica Chubak joined Group Health Research Institute (GHRI) in 2007 with a passion for epidemiology and translational research. With expertise in epidemiologic methods, pharmaco-epidemiology, and cancer, she is working with the Institute's cancer researchers to explore new inquiries in cancer screening and survivorship.

Dr. Chubak participates in the HMO Cancer Research Network and several projects on medication use and cancer risk and prognosis. She is especially interested in evaluating programs and translating research into practices that improve health and health care.

Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand. This unique background has helped shape her commitment to moving research innovations into daily practice, especially for cancer survivors. She is building a research program in survivorship focused on preventing cancer death, recurrence, and late and long-term effects of cancer treatment. She aims to develop epidemiologic methods for large-scale research on managing care for cancer survivors.

Top

Recent publications

Chubak J, Pocobelli G, Weiss NS. Trade-offs between accuracy measures for electronic healthcare data algorithms. J Clin Epidemiol. 2011 Dec 23. [Epub ahead of print]. PubMed

Liss DT, Chubak J, Anderson ML, Saunders KW, Tuzzio L, Reid RJ. Patient-reported care coordination: associations with primary care continuity and specialty care use. Ann Fam Med. 2011;9(4):323-9. PubMed

Chubak J, Hsu C, Tuzzio L, Kirlin B, Nekhlyudov L. C-a4-01: providing care for cancer survivors in integrated delivery systems: an assessment of current practices and future opportunities. Clin Med Res. 2010;8(3-4):182. PubMed

Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010;48(9):815-20. PubMed

Green BB, Wang CY, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S, Bogart A. Systems of support to increase colorectal cancer screening and follow-up rates (SOS): Design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov;31(6):589-603. Epub 2010 Jul 30. PubMed

Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011 Jan 1;128(1):227-32. Epub 2010 Mar 15. doi: 10.1002/ijc.25322. PubMed

Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009;27(27):4508-14. Epub 2009 Aug 17. PubMed

Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2152-4. PubMed

Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009;18(7):540-4. Epub 2009 Apr 14. PubMed

Chubak J, Boudreau D, Rulyak S, Mandelson M. Colorectal cancer risk in relation to antidepressant use. Cancer Epidemiol Biomarkers Prev. 2009;18(2):692.

Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DS. Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009;18(2):676-9. Epub 2009 Feb 3. PubMed

To view more publications, please see Dr. Chubak's CV.

Top

 

Site map Contact us ghc.orgJobs

Copyright Group Health Cooperative